Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
SIRT6, Nucleolar Remodeling, and Proteostasis
2026-09-15
The reference study identifies SIRT6-dependent nucleolar control as an upstream regulator of protein synthesis, folding capacity, and age-related proteostasis failure. Its combination of chromatin, translation, cellular stress, and C. elegans experiments suggests that reducing excessive translation may be a more mechanistically direct intervention than targeting aggregates after they form.
-
DMG-PEG2000-NH2: From SAR to Delivery
2026-09-15
DMG-PEG2000-NH2 is an NH2-PEG derivative that connects lipid assemblies with carboxyl-bearing biomolecules. This article translates structure–activity relationship thinking into more rigorous linker, LNP, liposome, and siRNA assay decisions.
-
Nitroaromatic Nannocystin Targets AKT1 in CRC
2026-09-14
This Acta Pharmacologica Sinica study identifies compound 4, a synthetic nitroaromatic nannocystin, as a potent colorectal cancer inhibitor with activity in cell lines, patient-derived organoids, and a xenograft model. Its integrated synthesis, phenotypic, transcriptomic, docking, and cellular thermal shift analyses support AKT1 engagement as part of the mechanism, while apoptosis and senescence provide important cellular readouts for follow-up studies.
-
Arachidonic Acid in Ischemia-Reperfusion Assays
2026-09-14
Use Arachidonic Acid to connect lipid mediator production with inflammatory, oxidative-stress, and blood-brain barrier readouts. This practical workflow complements the reference study’s selective hypothermic albumin strategy without implying that arachidonate was tested as a stroke treatment.
-
Cyclosporin Variants in Mitochondrial Membranes
2026-09-13
The reference study combines NMR spectroscopy, molecular dynamics, and calcium-dependent mitochondrial swelling assays to explain why closely related cyclosporin variants differ in mitochondrial pore activity. Its central finding is that cyclosporin E, the relatively more rigid congener, lacked detectable activity under the reported conditions, whereas cyclosporins B–D showed activity comparable to Cyclosporin A.
-
APEX2 Supports TERT Expression in Human Stem Cells
2026-09-12
A bioRxiv study identifies APEX2 as a previously unrecognized positive regulator of TERT expression in human embryonic stem cells and a melanoma cell line. Its RNA-seq and chromatin-immunoprecipitation data suggest that APEX2 may support transcription through repair-prone repetitive DNA within the TERT locus, although the causal mechanism remains to be established.
-
Sildenafil Citrate: From PDE5 to Proteoform-Aware Assays
2026-09-11
Sildenafil Citrate is a cGMP-specific phosphodiesterase type 5 inhibitor with applications spanning vascular signaling, ERK biology, and proteoform-aware drug research. This article translates native-membrane mass spectrometry findings into practical assay and interpretation strategies.
-
Cefoperazone: From β-Lactam Stability to Translation
2026-09-11
A thought-leadership guide to using Cefoperazone sodium salt for β-lactamase resistance studies, in vitro antimicrobial activity assays, comparative antibacterial profiling, and biliary tract infection research.
-
RHO P347L Retinitis Pigmentosa Mechanisms
2026-09-10
The 2026 study distinguishes RHO P347L from L125R retinitis pigmentosa by linking defective outer-segment trafficking to enhanced arrestin recruitment, endocytosis, lysosomal burden, and mitochondrial stress. Its integrated mouse and cell-based design provides a mechanistic explanation for the more severe degeneration associated with the Class 1 P347L mutation and clarifies which pathological features are shared between RHO variants.
-
SB-505124 hydrochloride in Mechanobiology
2026-09-10
SB-505124 hydrochloride provides a reversible way to test how TGF-β/activin signaling influences fibroblast state and cellular mechanics. This article connects ALK4/5/7 inhibition with the MRTFA–KCNMB1 stiffness framework while emphasizing assay controls, interpretation, and translational limits.
-
Peripheral Endosome Entrapment Limits LNP Escape
2026-09-09
This study shows that lipid nanoparticle uptake alone is an incomplete measure of delivery: accumulation in peripheral endosomes can restrict movement toward perinuclear lysosomal regions and reduce cytosolic cargo release. Its combination of sensitive LNP labeling with defined endolysosomal states provides a framework for optimizing the balance between cellular internalization, intracellular trafficking, degradation, and productive expression.
-
Minocycline HCl in Retinal Microglia Studies
2026-09-09
Minocycline HCl provides a practical pharmacological control for testing whether microglial activity is required for 40-Hz flicker–associated amyloid-β clearance. This workflow connects MHC-II biology with retinal imaging, molecular assays, ERG, and OKR while highlighting formulation and interpretation safeguards.
-
MRTFA-KCNMB1 Controls Cancer Cell Stiffness
2026-09-08
Gajda et al. identify potassium efflux and the BK-channel auxiliary subunit KCNMB1 as regulators of cancer-cell stiffness downstream of MRTFA. By integrating genetic perturbation, atomic force microscopy, electrophysiology, immune-cell cytotoxicity assays, transcriptomics, and mouse models, the study connects cancer-cell stiffening with improved lymphocyte-mediated clearance and reduced metastatic colonization.
-
Cisplatin (CDDP): Workflows and Troubleshooting
2026-09-08
Build reproducible Cisplatin workflows that connect DNA crosslinking with apoptosis, oxidative stress, and chemotherapy resistance studies. This guide also translates a renal-injury study into practical controls for cancer research without confusing toxicity biology with antitumor efficacy.
-
Doxycycline Hyclate as an MMP Inhibitor
2026-09-07
Doxycycline hyclate is a research-grade tetracycline derivative and matrix metalloproteinases inhibitor with reported activity against MMP-2, MMP-8, and MMP-9. In a sodium arsenite mouse model, doxycycline hyclate preserved blood-brain barrier integrity and improved cognitive outcomes, while separate product-dossier data describe antiviral and antimalarial activity in experimental systems.